Massachusetts Biofuel Plan Could Undercut Work Of Massachusetts Biotech Companies

Main Category: Pharma Industry / Biotech Industry
Article Date: 20 Aug 2009 - 12:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Healthcare Prof:not yet rated


Massachusetts' implementation plan for its Biofuels Mandate excludes biofuels made from renewable biomass being researched and developed by Massachusetts companies. The Biotechnology Industry Organization (BIO) today urged the Massachusetts Department of Energy Resources to accept applications for qualifying advanced biofuels from biofuel producers using all sources of renewable biomass, which have been shown to considerably reduce greenhouse gas emissions.

Brent Erickson, executive vice president of BIO's Industrial & Environmental Section, stated, "By permitting only biofuels made from waste feedstocks under its mandate, Massachusetts is preventing its own biotech companies from deploying their advanced technology to turn other sources of renewable biomass into advanced biofuels. The decisions released by the Massachusetts Department of Energy Resources will have a detrimental effect on Massachusetts' considerable bioscience industry, which employs millions of Massachusetts workers and attracts a tremendous amount of investment to the state. I am sure this effort is based on good intentions, but it sets a very bad precedent by excluding some of the most sustainable renewable resources from being utilized to make cleaner and greener transportation fuels. Massachusetts has several biotech companies that are leading the way to making advanced biofuels from very sustainable feedstocks. We are surprised to see the state disadvantage its own companies.

"Preliminary analysis by the U.S. Environmental Protection Agency shows that many biofuels can reduce greenhouse gas emissions by the 50 percent threshold in the Massachusetts law. The EPA's analysis even identifies use of biotechnology as one of the aspects of its 'best-case scenario.' However, the EPA's analysis of lifecycle emissions from biofuels are based on a model whose calculations are highly dependent on vague assumption. We believe Massachusetts may be making a grave mistake to cut off promising avenues of research and commercialization of advanced biofuels based on the preliminary results of this model."

The implementation plan released by Massachusetts' Department of Energy Resources says that applications for qualifying advanced biofuels will only be accepted for biofuels derived from waste feedstocks. Massachusetts law defines waste feedstocks as previously used or discarded material from industrial, commercial or household food service activities, including animal waste, animal by-products, organic portions of municipal solid waste, grease trap waste, construction and demolition debris. Other forms of renewable biomass - agricultural crop residues such as corn cobs, dedicated energy crops such as switch grass or other grasses, or algae - are therefore excluded.

Source
BIO

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
BIO. "Massachusetts Biofuel Plan Could Undercut Work Of Massachusetts Biotech Companies." Medical News Today. MediLexicon, Intl., 20 Aug. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/161330.php>

APA
BIO. (2009, August 20). "Massachusetts Biofuel Plan Could Undercut Work Of Massachusetts Biotech Companies." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/161330.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »